Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-04-22

AUTHORS

Mildred Fátima de la Luz Alvarez-Canales, Sara Stephania Salazar-López, Diana Farfán-Vázquez, Yosceline Estrella Martínez-López, Jessica Noemí González-Mena, Lilia Marisela Jiménez-Ceja, Katya Vargas-Ortiz, María Lola Evia-Viscarra, María Luisa Montes de Oca-Loyola, Franco Folli, Alberto Aguilar-García, Rodolfo Guardado-Mendoza

ABSTRACT

The goal of the study was to evaluate the effect of adding linagliptin to metformin and lifestyle on glucose levels and pancreatic β-cell function in patients with persistent impaired glucose tolerance (IGT) after 12 months of metformin and lifestyle. A single center parallel double-blind randomized clinical trial with 6 months of follow-up was performed in patients with persistent IGT after 12 months of treatment with metformin and lifestyle; patients were randomized to continue with metformin 850 mg twice daily (M group, n = 12) or linagliptin/metformin 2.5/850 mg twice daily (LM group, n = 19). Anthropometric measurements were obtained by standard methods and by bioelectrical impedance; glucose was measured by dry chemistry, insulin by chemiluminescence, and pancreatic β-cell function was calculated with the disposition index using glucose and insulin values during oral glucose tolerance test (OGTT) and adjusting by insulin sensitivity. The main outcomes were glucose levels during OGTT and pancreatic β-cell function. Patients in the LM group had a reduction in weight (−1.7 ± 0.6, p < 0.05) and body mass index (BMI, −0.67 ± 0.2, p < 0.05). Glucose levels significantly improved in LM group with a greater reduction in the area under the glucose curve during OGTT (AUCGluc0_120min) as compared to the M group (−4425 ± 871 vs −1116 ± 1104 mg/dl/120 min, p < 0.001). Pancreatic β-cell function measured with the disposition index, improved only in LM group (2.3 ± 0.23 vs 1.7 ± 0.27, p 0.001); these improvements persisted after controlling for OGTT glucose levels. The differences in pancreatic β-cell function persisted also after pairing groups for basal AUCGluc0_120min. The addition of linagliptin to patients with persistent IGT after 12 months of treatment with metformin and lifestyle, improved glucose levels during OGTT and pancreatic β-cell function after 6 months of treatment.Trial registration: Clinicaltrials.gov with the ID number NCT04088461 More... »

PAGES

8750

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-021-88108-8

DOI

http://dx.doi.org/10.1038/s41598-021-88108-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1137399806

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33888772


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucose Tolerance Test", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin Resistance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin-Secreting Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Life Style", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Linagliptin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metformin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prediabetic State", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alvarez-Canales", 
        "givenName": "Mildred F\u00e1tima de la Luz", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salazar-L\u00f3pez", 
        "givenName": "Sara Stephania", 
        "id": "sg:person.015413174527.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015413174527.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farf\u00e1n-V\u00e1zquez", 
        "givenName": "Diana", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mart\u00ednez-L\u00f3pez", 
        "givenName": "Yosceline Estrella", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonz\u00e1lez-Mena", 
        "givenName": "Jessica Noem\u00ed", 
        "id": "sg:person.014300001057.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014300001057.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jim\u00e9nez-Ceja", 
        "givenName": "Lilia Marisela", 
        "id": "sg:person.01151044766.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151044766.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Sciences, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medical Sciences, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vargas-Ortiz", 
        "givenName": "Katya", 
        "id": "sg:person.0627132144.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627132144.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology Department Hospital Regional de Alta Especialidad del Baj\u00edo, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.452473.3", 
          "name": [
            "Endocrinology Department Hospital Regional de Alta Especialidad del Baj\u00edo, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evia-Viscarra", 
        "givenName": "Mar\u00eda Lola", 
        "id": "sg:person.01037162267.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037162267.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.412891.7", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montes de Oca-Loyola", 
        "givenName": "Mar\u00eda Luisa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Asst Santi Paolo E Carlo, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Endocrinology and Metabolism Dipartimento Di Scienze Della Salute, Universita\u2019 Degli Studi Di Milano, Milan, Italy", 
            "Asst Santi Paolo E Carlo, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Folli", 
        "givenName": "Franco", 
        "id": "sg:person.0622273004.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622273004.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology Department Hospital Regional de Alta Especialidad del Baj\u00edo, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.452473.3", 
          "name": [
            "Endocrinology Department Hospital Regional de Alta Especialidad del Baj\u00edo, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aguilar-Garc\u00eda", 
        "givenName": "Alberto", 
        "id": "sg:person.016053127151.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016053127151.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Department Hospital Regional de Alta Especialidad del Baj\u00edo, Col. San Carlos La Roncha, Blvd.Milenio #130, 37660, Le\u00f3n, Guanajuato, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.452473.3", 
          "name": [
            "Department of Medicine and Nutrition, University of Guanajuato, Le\u00f3n, Guanajuato, Mexico", 
            "Research Department Hospital Regional de Alta Especialidad del Baj\u00edo, Col. San Carlos La Roncha, Blvd.Milenio #130, 37660, Le\u00f3n, Guanajuato, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guardado-Mendoza", 
        "givenName": "Rodolfo", 
        "id": "sg:person.01034616366.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034616366.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00125-016-3899-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000770298", 
          "https://doi.org/10.1007/s00125-016-3899-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-016-0904-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024180737", 
          "https://doi.org/10.1007/s00592-016-0904-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12889-020-8203-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124229647", 
          "https://doi.org/10.1186/s12889-020-8203-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-015-3625-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021479853", 
          "https://doi.org/10.1007/s00125-015-3625-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-016-4165-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013972642", 
          "https://doi.org/10.1007/s00125-016-4165-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6823-9-17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045668457", 
          "https://doi.org/10.1186/1472-6823-9-17"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-019-01411-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120687656", 
          "https://doi.org/10.1007/s00592-019-01411-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-018-4716-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106342269", 
          "https://doi.org/10.1007/s00125-018-4716-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-009-1614-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015988311", 
          "https://doi.org/10.1007/s00125-009-1614-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-04-22", 
    "datePublishedReg": "2021-04-22", 
    "description": "The goal of the study was to evaluate the effect of adding linagliptin to metformin and lifestyle on glucose levels and pancreatic \u03b2-cell function in patients with persistent impaired glucose tolerance (IGT) after 12\u00a0months of metformin and lifestyle. A single center parallel double-blind randomized clinical trial with 6\u00a0months of follow-up was performed in patients with persistent IGT after 12\u00a0months of treatment with metformin and lifestyle; patients were randomized to continue with metformin 850\u00a0mg twice daily (M group, n\u2009=\u200912) or linagliptin/metformin 2.5/850\u00a0mg twice daily (LM group, n\u2009=\u200919). Anthropometric measurements were obtained by standard methods and by bioelectrical impedance; glucose was measured by dry chemistry, insulin by chemiluminescence, and pancreatic \u03b2-cell function was calculated with the disposition index using glucose and insulin values during oral glucose tolerance test (OGTT) and adjusting by insulin sensitivity. The main outcomes were glucose levels during OGTT and pancreatic \u03b2-cell function. Patients in the LM group had a reduction in weight (\u22121.7\u2009\u00b1\u20090.6, p\u2009<\u20090.05) and body mass index (BMI, \u22120.67\u2009\u00b1\u20090.2, p\u2009<\u20090.05). Glucose levels significantly improved in LM group with a greater reduction in the area under the glucose curve during OGTT (AUCGluc0_120min) as compared to the M group (\u22124425\u2009\u00b1\u2009871 vs \u22121116\u2009\u00b1\u20091104\u00a0mg/dl/120\u00a0min, p\u2009<\u20090.001). Pancreatic \u03b2-cell function measured with the disposition index, improved only in LM group (2.3\u2009\u00b1\u20090.23 vs 1.7\u2009\u00b1\u20090.27, p 0.001); these improvements persisted after controlling for OGTT glucose levels. The differences in pancreatic \u03b2-cell function persisted also after pairing groups for basal AUCGluc0_120min. The addition of linagliptin to patients with persistent IGT after 12\u00a0months of treatment with metformin and lifestyle, improved glucose levels during OGTT and pancreatic \u03b2-cell function after 6\u00a0months of treatment.Trial registration: Clinicaltrials.gov with the ID number NCT04088461", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-021-88108-8", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "oral glucose tolerance test", 
      "pancreatic \u03b2-cell function", 
      "persistent impaired glucose tolerance", 
      "impaired glucose tolerance", 
      "\u03b2-cell function", 
      "months of treatment", 
      "glucose levels", 
      "LM group", 
      "disposition index", 
      "pancreatic beta-cell function", 
      "months of metformin", 
      "single-center parallel", 
      "addition of linagliptin", 
      "glucose tolerance test", 
      "body mass index", 
      "beta-cell function", 
      "OGTT glucose levels", 
      "metformin 850", 
      "persistent prediabetes", 
      "glucose tolerance", 
      "mass index", 
      "insulin values", 
      "tolerance test", 
      "clinical trials", 
      "insulin sensitivity", 
      "glucose curve", 
      "MAIN OUTCOME", 
      "anthropometric measurements", 
      "glucose metabolism", 
      "patients", 
      "metformin", 
      "M group", 
      "bioelectrical impedance", 
      "linagliptin", 
      "months", 
      "cell function", 
      "greater reduction", 
      "treatment", 
      "lifestyle", 
      "group", 
      "glucose", 
      "prediabetes", 
      "levels", 
      "index", 
      "insulin", 
      "dry chemistry", 
      "trials", 
      "center parallel", 
      "outcomes", 
      "metabolism", 
      "standard methods", 
      "function", 
      "reduction", 
      "effect", 
      "differences", 
      "weight", 
      "study", 
      "chemiluminescence", 
      "sensitivity", 
      "test", 
      "tolerance", 
      "improvement", 
      "addition", 
      "curves", 
      "area", 
      "goal", 
      "values", 
      "method", 
      "parallel", 
      "measurements", 
      "impedance", 
      "chemistry"
    ], 
    "name": "Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle", 
    "pagination": "8750", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1137399806"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-021-88108-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33888772"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-021-88108-8", 
      "https://app.dimensions.ai/details/publication/pub.1137399806"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_889.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-021-88108-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-021-88108-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-021-88108-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-021-88108-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-021-88108-8'


 

This table displays all metadata directly associated to this object as RDF triples.

317 TRIPLES      21 PREDICATES      122 URIs      105 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-021-88108-8 schema:about N319e227708b44a4b952f7a0159f5ff5c
2 N341ad700ded945eb9875d252e8b9a405
3 N37bed2429d604bcfbec041999f01f1da
4 N51856fa5f0724b46b5681ce02c0189ac
5 N648bc74273ca4b20be96c052f218452b
6 N695e6cc961b340a0bf79ec31791990d3
7 Na5147db0f8b04fc89629743305ff5caf
8 Na9f0bf4eae3d41b0b63158f1a1ed8a89
9 Nb2e5ded25a054370b16f35ed4c3f8f5d
10 Nb8da1ddba6234015b3719beaea354dd1
11 Nc14eb8d4b6624260b4f6e06ea5d2e530
12 Ncec5a295a3154a3ca8ac42bc384ff6f2
13 Nd790766efba9448593478080d3b9cdfc
14 Ndbef7c7a65d94e42aedf00b4f3f801fd
15 Nf721cd8ef8ce42ebb2cfa053fcf10144
16 Nfc5c1358ffd34dda80130249be4d45b5
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author Nda3e3b15a5e74619a1ac95ed145b7f8d
20 schema:citation sg:pub.10.1007/s00125-009-1614-2
21 sg:pub.10.1007/s00125-015-3625-5
22 sg:pub.10.1007/s00125-016-3899-2
23 sg:pub.10.1007/s00125-016-4165-3
24 sg:pub.10.1007/s00125-018-4716-x
25 sg:pub.10.1007/s00592-016-0904-7
26 sg:pub.10.1007/s00592-019-01411-9
27 sg:pub.10.1186/1472-6823-9-17
28 sg:pub.10.1186/s12889-020-8203-1
29 schema:datePublished 2021-04-22
30 schema:datePublishedReg 2021-04-22
31 schema:description The goal of the study was to evaluate the effect of adding linagliptin to metformin and lifestyle on glucose levels and pancreatic β-cell function in patients with persistent impaired glucose tolerance (IGT) after 12 months of metformin and lifestyle. A single center parallel double-blind randomized clinical trial with 6 months of follow-up was performed in patients with persistent IGT after 12 months of treatment with metformin and lifestyle; patients were randomized to continue with metformin 850 mg twice daily (M group, n = 12) or linagliptin/metformin 2.5/850 mg twice daily (LM group, n = 19). Anthropometric measurements were obtained by standard methods and by bioelectrical impedance; glucose was measured by dry chemistry, insulin by chemiluminescence, and pancreatic β-cell function was calculated with the disposition index using glucose and insulin values during oral glucose tolerance test (OGTT) and adjusting by insulin sensitivity. The main outcomes were glucose levels during OGTT and pancreatic β-cell function. Patients in the LM group had a reduction in weight (−1.7 ± 0.6, p < 0.05) and body mass index (BMI, −0.67 ± 0.2, p < 0.05). Glucose levels significantly improved in LM group with a greater reduction in the area under the glucose curve during OGTT (AUCGluc0_120min) as compared to the M group (−4425 ± 871 vs −1116 ± 1104 mg/dl/120 min, p < 0.001). Pancreatic β-cell function measured with the disposition index, improved only in LM group (2.3 ± 0.23 vs 1.7 ± 0.27, p 0.001); these improvements persisted after controlling for OGTT glucose levels. The differences in pancreatic β-cell function persisted also after pairing groups for basal AUCGluc0_120min. The addition of linagliptin to patients with persistent IGT after 12 months of treatment with metformin and lifestyle, improved glucose levels during OGTT and pancreatic β-cell function after 6 months of treatment.Trial registration: Clinicaltrials.gov with the ID number NCT04088461
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf Ne6bce4eefaf1484a84e0f0eb26cb0025
35 Nefb498846823450ba236097529b3cdfb
36 sg:journal.1045337
37 schema:keywords LM group
38 M group
39 MAIN OUTCOME
40 OGTT glucose levels
41 addition
42 addition of linagliptin
43 anthropometric measurements
44 area
45 beta-cell function
46 bioelectrical impedance
47 body mass index
48 cell function
49 center parallel
50 chemiluminescence
51 chemistry
52 clinical trials
53 curves
54 differences
55 disposition index
56 dry chemistry
57 effect
58 function
59 glucose
60 glucose curve
61 glucose levels
62 glucose metabolism
63 glucose tolerance
64 glucose tolerance test
65 goal
66 greater reduction
67 group
68 impaired glucose tolerance
69 impedance
70 improvement
71 index
72 insulin
73 insulin sensitivity
74 insulin values
75 levels
76 lifestyle
77 linagliptin
78 mass index
79 measurements
80 metabolism
81 metformin
82 metformin 850
83 method
84 months
85 months of metformin
86 months of treatment
87 oral glucose tolerance test
88 outcomes
89 pancreatic beta-cell function
90 pancreatic β-cell function
91 parallel
92 patients
93 persistent impaired glucose tolerance
94 persistent prediabetes
95 prediabetes
96 reduction
97 sensitivity
98 single-center parallel
99 standard methods
100 study
101 test
102 tolerance
103 tolerance test
104 treatment
105 trials
106 values
107 weight
108 β-cell function
109 schema:name Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle
110 schema:pagination 8750
111 schema:productId N32f93ae345b44bfe941bfec2cf335a17
112 N777a3ca0dcc04f3d82364b9f772d3ca9
113 Ndf52b58b92a142c3ae8f460e4e354083
114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1137399806
115 https://doi.org/10.1038/s41598-021-88108-8
116 schema:sdDatePublished 2022-12-01T06:42
117 schema:sdLicense https://scigraph.springernature.com/explorer/license/
118 schema:sdPublisher Ndc62681ea44e4e88929d38a009f27560
119 schema:url https://doi.org/10.1038/s41598-021-88108-8
120 sgo:license sg:explorer/license/
121 sgo:sdDataset articles
122 rdf:type schema:ScholarlyArticle
123 N001f0d14eaa44948baa14668736ed9b0 rdf:first N47cb62024708496ab605fd87078b9d11
124 rdf:rest N2d331f8b1db941dcb9c259e5202d5f5a
125 N2ac57f83d1e34c45abfddb8e107bcdb1 schema:affiliation grid-institutes:grid.412891.7
126 schema:familyName Montes de Oca-Loyola
127 schema:givenName María Luisa
128 rdf:type schema:Person
129 N2d331f8b1db941dcb9c259e5202d5f5a rdf:first sg:person.014300001057.45
130 rdf:rest Na6340a5dc3a547b0b49c0320219e56a6
131 N2ef890babc1142eeb90bfde5fcd8238d rdf:first sg:person.0627132144.73
132 rdf:rest Ne4cf75962c8548c4b8e56130bc12e664
133 N319e227708b44a4b952f7a0159f5ff5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Glucose
135 rdf:type schema:DefinedTerm
136 N32f93ae345b44bfe941bfec2cf335a17 schema:name pubmed_id
137 schema:value 33888772
138 rdf:type schema:PropertyValue
139 N341ad700ded945eb9875d252e8b9a405 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Linagliptin
141 rdf:type schema:DefinedTerm
142 N37bed2429d604bcfbec041999f01f1da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Insulin Resistance
144 rdf:type schema:DefinedTerm
145 N4751c0ff6bca4f0faf1eb4fe165673e8 schema:affiliation grid-institutes:grid.412891.7
146 schema:familyName Farfán-Vázquez
147 schema:givenName Diana
148 rdf:type schema:Person
149 N47cb62024708496ab605fd87078b9d11 schema:affiliation grid-institutes:grid.412891.7
150 schema:familyName Martínez-López
151 schema:givenName Yosceline Estrella
152 rdf:type schema:Person
153 N51856fa5f0724b46b5681ce02c0189ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 N648bc74273ca4b20be96c052f218452b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Insulin-Secreting Cells
158 rdf:type schema:DefinedTerm
159 N695e6cc961b340a0bf79ec31791990d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Metformin
161 rdf:type schema:DefinedTerm
162 N777a3ca0dcc04f3d82364b9f772d3ca9 schema:name dimensions_id
163 schema:value pub.1137399806
164 rdf:type schema:PropertyValue
165 N7b06bb238fcc4d6e9a094eab8d2ec5ea rdf:first N2ac57f83d1e34c45abfddb8e107bcdb1
166 rdf:rest Nb6be1aaee5484eba940b6c586750636e
167 N974e2bfc00444c9bb4c3e8f8dda57999 rdf:first N4751c0ff6bca4f0faf1eb4fe165673e8
168 rdf:rest N001f0d14eaa44948baa14668736ed9b0
169 Na5147db0f8b04fc89629743305ff5caf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Drug Therapy, Combination
171 rdf:type schema:DefinedTerm
172 Na6340a5dc3a547b0b49c0320219e56a6 rdf:first sg:person.01151044766.17
173 rdf:rest N2ef890babc1142eeb90bfde5fcd8238d
174 Na9f0bf4eae3d41b0b63158f1a1ed8a89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Prediabetic State
176 rdf:type schema:DefinedTerm
177 Nb2e5ded25a054370b16f35ed4c3f8f5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Insulin
179 rdf:type schema:DefinedTerm
180 Nb6be1aaee5484eba940b6c586750636e rdf:first sg:person.0622273004.10
181 rdf:rest Ne6fd12c9964148e39a0d1c0ac45fa3dc
182 Nb8da1ddba6234015b3719beaea354dd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Female
184 rdf:type schema:DefinedTerm
185 Nc14eb8d4b6624260b4f6e06ea5d2e530 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Glucose Tolerance Test
187 rdf:type schema:DefinedTerm
188 Ncba22af8d19c42cf8f68a8ba15949078 rdf:first sg:person.015413174527.66
189 rdf:rest N974e2bfc00444c9bb4c3e8f8dda57999
190 Ncec5a295a3154a3ca8ac42bc384ff6f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Double-Blind Method
192 rdf:type schema:DefinedTerm
193 Nd790766efba9448593478080d3b9cdfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Hypoglycemic Agents
195 rdf:type schema:DefinedTerm
196 Nda3e3b15a5e74619a1ac95ed145b7f8d rdf:first Nde64a58f803b48618c0fa197cd6af4dc
197 rdf:rest Ncba22af8d19c42cf8f68a8ba15949078
198 Ndbef7c7a65d94e42aedf00b4f3f801fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Life Style
200 rdf:type schema:DefinedTerm
201 Ndc62681ea44e4e88929d38a009f27560 schema:name Springer Nature - SN SciGraph project
202 rdf:type schema:Organization
203 Nde64a58f803b48618c0fa197cd6af4dc schema:affiliation grid-institutes:grid.412891.7
204 schema:familyName Alvarez-Canales
205 schema:givenName Mildred Fátima de la Luz
206 rdf:type schema:Person
207 Ndf52b58b92a142c3ae8f460e4e354083 schema:name doi
208 schema:value 10.1038/s41598-021-88108-8
209 rdf:type schema:PropertyValue
210 Ne4cf75962c8548c4b8e56130bc12e664 rdf:first sg:person.01037162267.17
211 rdf:rest N7b06bb238fcc4d6e9a094eab8d2ec5ea
212 Ne6bce4eefaf1484a84e0f0eb26cb0025 schema:volumeNumber 11
213 rdf:type schema:PublicationVolume
214 Ne6fd12c9964148e39a0d1c0ac45fa3dc rdf:first sg:person.016053127151.63
215 rdf:rest Nec52a5dbc8714da7bb336dec6ac47c40
216 Nec52a5dbc8714da7bb336dec6ac47c40 rdf:first sg:person.01034616366.33
217 rdf:rest rdf:nil
218 Nefb498846823450ba236097529b3cdfb schema:issueNumber 1
219 rdf:type schema:PublicationIssue
220 Nf721cd8ef8ce42ebb2cfa053fcf10144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Male
222 rdf:type schema:DefinedTerm
223 Nfc5c1358ffd34dda80130249be4d45b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Middle Aged
225 rdf:type schema:DefinedTerm
226 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
227 schema:name Medical and Health Sciences
228 rdf:type schema:DefinedTerm
229 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
230 schema:name Clinical Sciences
231 rdf:type schema:DefinedTerm
232 sg:journal.1045337 schema:issn 2045-2322
233 schema:name Scientific Reports
234 schema:publisher Springer Nature
235 rdf:type schema:Periodical
236 sg:person.01034616366.33 schema:affiliation grid-institutes:grid.452473.3
237 schema:familyName Guardado-Mendoza
238 schema:givenName Rodolfo
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034616366.33
240 rdf:type schema:Person
241 sg:person.01037162267.17 schema:affiliation grid-institutes:grid.452473.3
242 schema:familyName Evia-Viscarra
243 schema:givenName María Lola
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037162267.17
245 rdf:type schema:Person
246 sg:person.01151044766.17 schema:affiliation grid-institutes:grid.412891.7
247 schema:familyName Jiménez-Ceja
248 schema:givenName Lilia Marisela
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151044766.17
250 rdf:type schema:Person
251 sg:person.014300001057.45 schema:affiliation grid-institutes:grid.412891.7
252 schema:familyName González-Mena
253 schema:givenName Jessica Noemí
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014300001057.45
255 rdf:type schema:Person
256 sg:person.015413174527.66 schema:affiliation grid-institutes:grid.412891.7
257 schema:familyName Salazar-López
258 schema:givenName Sara Stephania
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015413174527.66
260 rdf:type schema:Person
261 sg:person.016053127151.63 schema:affiliation grid-institutes:grid.452473.3
262 schema:familyName Aguilar-García
263 schema:givenName Alberto
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016053127151.63
265 rdf:type schema:Person
266 sg:person.0622273004.10 schema:affiliation grid-institutes:None
267 schema:familyName Folli
268 schema:givenName Franco
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622273004.10
270 rdf:type schema:Person
271 sg:person.0627132144.73 schema:affiliation grid-institutes:grid.412891.7
272 schema:familyName Vargas-Ortiz
273 schema:givenName Katya
274 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627132144.73
275 rdf:type schema:Person
276 sg:pub.10.1007/s00125-009-1614-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015988311
277 https://doi.org/10.1007/s00125-009-1614-2
278 rdf:type schema:CreativeWork
279 sg:pub.10.1007/s00125-015-3625-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021479853
280 https://doi.org/10.1007/s00125-015-3625-5
281 rdf:type schema:CreativeWork
282 sg:pub.10.1007/s00125-016-3899-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000770298
283 https://doi.org/10.1007/s00125-016-3899-2
284 rdf:type schema:CreativeWork
285 sg:pub.10.1007/s00125-016-4165-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013972642
286 https://doi.org/10.1007/s00125-016-4165-3
287 rdf:type schema:CreativeWork
288 sg:pub.10.1007/s00125-018-4716-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1106342269
289 https://doi.org/10.1007/s00125-018-4716-x
290 rdf:type schema:CreativeWork
291 sg:pub.10.1007/s00592-016-0904-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024180737
292 https://doi.org/10.1007/s00592-016-0904-7
293 rdf:type schema:CreativeWork
294 sg:pub.10.1007/s00592-019-01411-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120687656
295 https://doi.org/10.1007/s00592-019-01411-9
296 rdf:type schema:CreativeWork
297 sg:pub.10.1186/1472-6823-9-17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045668457
298 https://doi.org/10.1186/1472-6823-9-17
299 rdf:type schema:CreativeWork
300 sg:pub.10.1186/s12889-020-8203-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124229647
301 https://doi.org/10.1186/s12889-020-8203-1
302 rdf:type schema:CreativeWork
303 grid-institutes:None schema:alternateName Asst Santi Paolo E Carlo, Milan, Italy
304 schema:name Asst Santi Paolo E Carlo, Milan, Italy
305 Endocrinology and Metabolism Dipartimento Di Scienze Della Salute, Universita’ Degli Studi Di Milano, Milan, Italy
306 rdf:type schema:Organization
307 grid-institutes:grid.412891.7 schema:alternateName Department of Medical Sciences, University of Guanajuato, León, Guanajuato, Mexico
308 Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico
309 schema:name Department of Medical Sciences, University of Guanajuato, León, Guanajuato, Mexico
310 Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico
311 rdf:type schema:Organization
312 grid-institutes:grid.452473.3 schema:alternateName Endocrinology Department Hospital Regional de Alta Especialidad del Bajío, León, Guanajuato, Mexico
313 Research Department Hospital Regional de Alta Especialidad del Bajío, Col. San Carlos La Roncha, Blvd.Milenio #130, 37660, León, Guanajuato, Mexico
314 schema:name Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico
315 Endocrinology Department Hospital Regional de Alta Especialidad del Bajío, León, Guanajuato, Mexico
316 Research Department Hospital Regional de Alta Especialidad del Bajío, Col. San Carlos La Roncha, Blvd.Milenio #130, 37660, León, Guanajuato, Mexico
317 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...